Recent efforts have demonstrated the in situ use of NIR spectroscopy t
o determine the homogeneity and potency of powder blends. This work ha
s raised questions regarding the effective mass of a powder blend inte
rrogated by a fiber-optic probe. The effective mass determined from ex
periments described herein is wavelength dependent and ranges from 0.1
54 to 0.858 g with a maximum standard deviation of about 0.16 g. Altho
ugh the precision of this estimate is low, it is sufficiently accurate
to demonstrate the usefulness of in situ NIR monitoring of blending o
perations in the pharmaceutical industry, The method was established b
y using the relationship between sample mass and spectral variance, Mi
xtures of lactose (50% w/w), microcrystalline cellulose (40% w/w), and
sodium benzoate (10% w/w) were manually blended and sampled at select
ed intervals, The spectral variance at relevant wavelengths was determ
ined as a function of blend homogeneity and sample mass using a standa
rd micro-sample cup. The spectral variance obtained from micro-cup mea
surements was used to calibrate the effective mass sampled by a fiber-
optic reflectance probe. The estimated mass was greatest at wavelength
s where the minor constituent contributed most to the overall spectral
variance. Typical pharmaceutical tablets have weights in the range of
0.1-1.0 g. According to FDA regulations, the maximum allowed sample m
ass for determining the homogeneity of these preparations is 0.3-3.0 g
, For many formulations, the effective mass sampled by the fiber-optic
probe easily falls below this range.